Literature DB >> 6586447

The biodisposition of almitrine bismesylate in man: a review.

D B Campbell, B Gordon, A Taylor, D Taylor, J Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6586447

Source DB:  PubMed          Journal:  Eur J Respir Dis Suppl        ISSN: 0106-4347


× No keyword cloud information.
  7 in total

1.  Extensive oxidative metabolism of dextromethorphan in patients with almitrine neuropathy.

Authors:  L Belec; D Larrey; H De Cremoux; M Tinel; F Louarn; D Pessayre; R Gherardi
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

Review 2.  Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infections.

Authors:  K F Chung; P J Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-09

3.  Metabolism of almitrine in extensive and poor metabolisers of debrisoquine/sparteine.

Authors:  A Herchuelz; D Gangji; F Derenne; J P Jeanniot; J Douchamps
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

4.  Almitrine bismesylate disposition in the human digestive tract.

Authors:  N Vidon; S Chaussade; J P Jeanniot; B Huchet; C Franchisseur; J J Bernier
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Peripheral nerve function in patients with chronic bronchitis receiving almitrine or placebo.

Authors:  M B Allen; K Prowse
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

Review 6.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

7.  Lipidosis of the dorsal root ganglia in rats treated with an almitrine metabolite.

Authors:  Y Yamanaka; E Sakamoto; Y Sakuma; H Uno; T Koyama; Y Izawa; K Fujiwara
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.